WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2023)
Top pharmaceutical stocks in 2023 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
VTRS
VIATRIS INC
$11.01B$9.18$10.3312.56%Sell3-0.59%29.63%N/AN/A
NBIX
NEUROCRINE BIOSCIENCES INC
$11.46B$116.59$130.9312.30%Buy1512.01%55.44%N/AN/A
COLL
COLLEGIUM PHARMACEUTICAL INC
$835.82M$25.63$36.0040.46%Buy12.82%293.90%N/AN/A
KMDA
KAMADA LTD
$212.06M$4.73$11.00132.56%Buy18.40%35.51%N/AN/A
ANIP
ANI PHARMACEUTICALS INC
$1.02B$49.81$71.6743.88%Strong Buy34.35%116.17%N/AN/A
LNTH
LANTHEUS HOLDINGS INC
$4.91B$71.62$109.6053.03%Strong Buy56.46%42.31%N/AN/A
SCYX
SCYNEXIS INC
$62.51M$1.68$15.00792.86%Strong Buy1-30.79%N/AN/AN/A
AMPH
AMPHASTAR PHARMACEUTICALS INC
$2.70B$56.32$66.5018.08%Buy214.63%-13.35%N/AN/A
ORGO
ORGANOGENESIS HOLDINGS INC
$336.70M$2.55$3.7547.06%Buy21.11%109.76%N/AN/A
PAHC
PHIBRO ANIMAL HEALTH CORP
$388.43M$9.59$18.5092.91%Buy23.46%48.71%N/AN/A
TXMD
THERAPEUTICSMD INC
$27.28M$2.58$5.0093.80%Hold1366.99%-61.11%N/AN/A
CRON
CRONOS GROUP INC
$769.85M$2.02N/AN/AN/AN/A16.96%N/AN/AN/A
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
$16.30M$0.46N/AN/AN/AN/AN/AN/AN/AN/A
AGRX
AGILE THERAPEUTICS INC
$5.30M$2.11$8.50302.84%Strong Buy255.13%-61.63%N/AN/A
ACRX
ACELRX PHARMACEUTICALS INC
$12.46M$0.74$4.63529.25%Strong Buy296.88%N/AN/AN/A
ZTS
ZOETIS INC
$81.11B$176.67$215.6022.04%Strong Buy55.47%12.17%N/AN/A
PCRX
PACIRA BIOSCIENCES INC
$1.27B$27.28$52.0090.62%Strong Buy76.30%225.69%N/AN/A
RDY
DR REDDYS LABORATORIES LTD
$11.64B$69.90$70.000.14%Strong Buy17.70%N/AN/AN/A
ETON
ETON PHARMACEUTICALS INC
$90.83M$3.54$10.00182.49%Buy1-8.59%N/A19.75%10.58%
ITCI
INTRA-CELLULAR THERAPIES INC
$5.91B$61.37$78.2027.42%Strong Buy527.99%N/AN/AN/A
HROW
HARROW INC
$324.14M$9.23$45.00387.54%Strong Buy122.56%N/AN/AN/A
SUPN
SUPERNUS PHARMACEUTICALS INC
$1.49B$27.25$43.0057.80%Strong Buy11.70%84.93%N/AN/A
PROC
PROCAPS GROUP SA
$279.80M$2.48$4.5081.45%Hold12.27%N/AN/AN/A
ZOM
ZOMEDICA CORP
$164.63M$0.17N/AN/AN/AN/AN/AN/AN/AN/A
EGRX
EAGLE PHARMACEUTICALS INC
$75.97M$5.85$17.00190.60%Strong Sell1-5.32%-26.28%N/AN/A
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.77B$13.70$27.50100.73%Buy2-3.93%N/AN/AN/A
DCPH
DECIPHERA PHARMACEUTICALS INC
$1.01B$12.61$22.4077.64%Buy517.25%N/AN/AN/A
TLRY
TILRAY BRANDS INC
$1.32B$1.81$2.5038.12%Hold115.34%N/A6.05%4.64%
SIGA
SIGA TECHNOLOGIES INC
$386.03M$5.43N/AN/AN/AN/A396.02%N/A41.23%32.32%
GHSI
GUARDION HEALTH SCIENCES INC
$7.56M$5.93N/AN/AN/AN/AN/AN/AN/AN/A
ALKS
ALKERMES PLC
$4.03B$24.14$33.5038.77%Buy6-1.87%4.06%N/AN/A
FTLF
FITLIFE BRANDS INC
$87.98M$19.17N/AN/AN/AN/AN/AN/AN/AN/A
AMRX
AMNEAL PHARMACEUTICALS INC
$1.32B$4.31$5.6731.48%Strong Buy33.51%234.72%N/AN/A
ASRT
ASSERTIO HOLDINGS INC
$96.56M$1.02$4.00292.16%Buy1-4.52%N/AN/AN/A
PETQ
PETIQ INC
$512.62M$17.42$29.3368.39%Strong Buy33.52%68.10%N/AN/A
EOLS
EVOLUS INC
$541.22M$9.47$23.00142.87%Strong Buy320.48%N/AN/AN/A
AYTU
AYTU BIOPHARMA INC
$12.75M$2.29$5.00118.34%Strong Buy1N/AN/AN/AN/A
DRRX
DURECT CORP
$18.49M$0.62$34.005,383.87%Strong Buy278.97%N/AN/AN/A
CLVR
CLEVER LEAVES HOLDINGS INC
$3.75M$2.15$24.001,016.28%Hold1N/AN/AN/AN/A
SBFM
SUNSHINE BIOPHARMA INC
$7.42M$0.29$2.60799.65%Strong Buy1N/AN/AN/AN/A
ACOR
ACORDA THERAPEUTICS INC
$12.17M$9.80N/AN/AN/AN/AN/AN/AN/AN/A
CPIX
CUMBERLAND PHARMACEUTICALS INC
$23.38M$1.64N/AN/AN/AN/AN/AN/AN/AN/A
OGI
ORGANIGRAM HOLDINGS INC
$103.03M$1.28$4.00212.50%Strong Buy117.57%N/AN/AN/A
OPTN
OPTINOSE INC
$140.39M$1.25$3.00140.00%Strong Buy222.82%N/AN/AN/A
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
$1.35B$36.00N/AN/AN/AN/A4.25%N/AN/AN/A
RMTI
ROCKWELL MEDICAL INC
$50.85M$1.79$8.00348.18%Strong Buy23.42%N/AN/AN/A
AVDL
AVADEL PHARMACEUTICALS PLC
$1.04B$11.54$20.7579.81%Strong Buy4213.90%N/AN/AN/A
KALA
KALA BIO INC
$16.29M$6.05$22.00263.64%Buy1N/AN/AN/AN/A
PRGO
PERRIGO CO PLC
$4.13B$30.46$42.5039.53%Strong Buy23.27%N/AN/AN/A
EVOK
EVOKE PHARMA INC
$4.34M$1.30N/AN/AN/AN/AN/AN/AN/AN/A
SXTC
CHINA SXT PHARMACEUTICALS INC
$969.61k$2.12N/AN/AN/AN/AN/AN/AN/AN/A
ACB
AURORA CANNABIS INC
$193.48M$0.46$0.9095.65%Hold24.46%N/AN/AN/A
CGC
CANOPY GROWTH CORP
$464.29M$0.56$0.583.57%Sell2-1.76%N/A7.58%3.40%
ESPR
ESPERION THERAPEUTICS INC
$151.24M$1.33$11.33752.11%Strong Buy361.82%N/AN/AN/A
HCM
HUTCHMED (CHINA) LTD
$3.34B$19.28$29.7054.05%Strong Buy30.22%N/AN/AN/A
CTLT
CATALENT INC
$7.00B$38.85$50.5830.20%Buy123.62%278.17%N/AN/A
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$8.00M$0.50N/AN/AN/AN/AN/AN/AN/AN/A
PRFX
PAINREFORM LTD
$2.73M$2.50N/AN/AN/AN/AN/AN/AN/AN/A
RDHL
REDHILL BIOPHARMA LTD
$7.67M$2.00N/AN/AN/AN/AN/AN/AN/AN/A
IXHL
INCANNEX HEALTHCARE LTD
$126.80M$7.99N/AN/AN/AN/AN/AN/AN/AN/A
NEPT
NEPTUNE WELLNESS SOLUTIONS INC
$3.67M$0.81N/AN/AN/AN/A64.60%N/AN/A-1,403.62%
TKNO
ALPHA TEKNOVA INC
$83.08M$2.04$6.00194.12%Strong Buy112.71%N/AN/AN/A
ALIM
ALIMERA SCIENCES INC
$161.71M$3.09$6.50110.70%Strong Buy216.24%N/AN/AN/A
DMK
DMK PHARMACEUTICALS CORP
$5.48M$0.54N/AN/AN/AN/A134.62%N/AN/AN/A
BFRI
BIOFRONTERA INC
$5.08M$3.35$18.00437.96%Strong Buy121.47%N/AN/AN/A
PTPI
PETROS PHARMACEUTICALS INC
$3.52M$1.60N/AN/AN/AN/AN/AN/AN/AN/A
SCTL
SOCIETAL CDMO INC
$38.77M$0.37$1.88406.76%Strong Buy210.24%N/AN/AN/A
CPHI
CHINA PHARMA HOLDINGS INC
$3.72M$0.11N/AN/AN/AN/AN/AN/AN/AN/A
CRDL
CARDIOL THERAPEUTICS INC
$59.35M$0.92$3.00227.51%Strong Buy1N/AN/AN/AN/A
INCR
INTERCURE LTD
$56.05M$1.23N/AN/AN/AN/AN/AN/AN/AN/A
UPC
UNIVERSE PHARMACEUTICALS INC
$3.06M$0.85N/AN/AN/AN/AN/AN/AN/AN/A
FLGC
FLORA GROWTH CORP
$9.44M$1.15N/AN/AN/AN/A2.81%N/A-366.79%-166.25%
ALVO
ALVOTECH
$2.53B$9.50$10.005.26%Hold299.42%N/AN/AN/A
SNOA
SONOMA PHARMACEUTICALS INC
$2.41M$0.18$3.251,746.59%Strong Buy1N/AN/AN/AN/A
COSM
COSMOS HEALTH INC
$13.94M$1.04N/AN/AN/AN/AN/AN/AN/AN/A
DERM
JOURNEY MEDICAL CORP
$79.03M$4.27$6.0040.52%Strong Buy12.70%N/AN/AN/A
SHOT
SAFETY SHOT INC
$178.38M$4.48N/AN/AN/AN/AN/AN/AN/AN/A
AKAN
AKANDA CORP
$1.70M$0.49N/AN/AN/AN/AN/AN/AN/AN/A
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
$141.06M$10.84N/AN/AN/AN/AN/AN/AN/AN/A
ELAN
ELANCO ANIMAL HEALTH INC
$5.81B$11.78$12.385.05%Sell42.07%N/AN/AN/A
EBS
EMERGENT BIOSOLUTIONS INC
$110.87M$2.14N/AN/AN/AN/A1.96%N/AN/AN/A
IRWD
IRONWOOD PHARMACEUTICALS INC
$1.55B$9.90$22.00122.22%Buy16.63%N/AN/AN/A
TAK
TAKEDA PHARMACEUTICAL CO LTD
$44.40B$14.15N/AN/AN/AN/A-0.88%N/AN/AN/A
HLN
HALEON PLC
$39.52B$8.56$9.005.14%Strong Buy1-0.60%15.74%N/AN/A
AQST
AQUESTIVE THERAPEUTICS INC
$150.23M$2.25$6.00166.67%Buy33.16%N/AN/AN/A
HUGE
FSD PHARMA INC
$41.33M$1.05N/AN/AN/AN/AN/AN/AN/AN/A
YCBD
CBDMD INC
$2.00M$0.70$3.00328.57%Strong Buy1N/AN/AN/AN/A
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$11.01B$9.82$13.0032.38%Strong Buy20.83%N/AN/AN/A
PBH
PRESTIGE CONSUMER HEALTHCARE INC
$2.85B$57.35$60.004.62%Hold11.70%N/AN/AN/A
BHC
BAUSCH HEALTH COMPANIES INC
$2.61B$7.14$16.00124.09%Strong Buy11.62%N/AN/AN/A
EVO
EVOTEC SE
$3.55B$10.01N/AN/AN/AN/AN/AN/AN/AN/A
CYTH
CYCLO THERAPEUTICS INC
$32.73M$1.44$4.00177.78%Strong Buy1N/AN/AN/AN/A
LSDI
LUCY SCIENTIFIC DISCOVERY INC
$3.49M$0.20N/AN/AN/AN/AN/AN/AN/AN/A
LFCR
LIFECORE BIOMEDICAL INC
$217.41M$7.17$9.5032.50%Buy2-3.68%N/AN/AN/A
BGXX
BRIGHT GREEN CORP
$50.57M$0.28N/AN/AN/AN/AN/AN/AN/AN/A
INDV
INDIVIOR PLC
$2.33B$16.92N/AN/AN/AN/AN/AN/AN/AN/A

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Dec 2023?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the top pharmaceutical stock with a Zen Score of 59, which is 33 points higher than the pharmaceutical industry average of 26. It passed 21 out of 38 due diligence checks and has strong fundamentals. Viatris has seen its stock lose -16.77% over the past year, underperforming other pharmaceutical stocks by -1 percentage points.

Viatris has an average 1 year price target of $10.33, an upside of 12.56% from Viatris's current stock price of $9.18.

Viatris stock has a consensus Sell recommendation according to Wall Street analysts. Of the 3 analysts covering Viatris, 0% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 33.33% have issued a Sell rating, and 33.33% have issued a Strong Sell.

2. Neurocrine Biosciences (NASDAQ:NBIX)


Neurocrine Biosciences (NASDAQ:NBIX) is the second best pharmaceutical stock with a Zen Score of 53, which is 27 points higher than the pharmaceutical industry average of 26. It passed 18 out of 33 due diligence checks and has strong fundamentals. Neurocrine Biosciences has seen its stock lose -8.24% over the past year, overperforming other pharmaceutical stocks by 7 percentage points.

Neurocrine Biosciences has an average 1 year price target of $130.93, an upside of 12.3% from Neurocrine Biosciences's current stock price of $116.59.

Neurocrine Biosciences stock has a consensus Buy recommendation according to Wall Street analysts. Of the 15 analysts covering Neurocrine Biosciences, 40% have issued a Strong Buy rating, 33.33% have issued a Buy, 26.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the third best pharmaceutical stock with a Zen Score of 51, which is 25 points higher than the pharmaceutical industry average of 26. It passed 16 out of 33 due diligence checks and has strong fundamentals. Collegium Pharmaceutical has seen its stock return 17.19% over the past year, overperforming other pharmaceutical stocks by 33 percentage points.

Collegium Pharmaceutical has an average 1 year price target of $36.00, an upside of 40.46% from Collegium Pharmaceutical's current stock price of $25.63.

Collegium Pharmaceutical stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Collegium Pharmaceutical, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 8 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 8.29%, which is 5 percentage points higher than the pharmaceutical industry average of 3.34%.

Siga Technologies's dividend payout ratio of -562.5% indicates that its high dividend yield might not be sustainable for the long-term.

2. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 5.01%, which is 2 percentage points higher than the pharmaceutical industry average of 3.34%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 92.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Alkermes (NASDAQ:ALKS)


Alkermes (NASDAQ:ALKS) has an annual dividend yield of 4.43%, which is 1 percentage points higher than the pharmaceutical industry average of 3.34%.

Alkermes's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 1.28% in the last day, and up 0.03% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are up.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Viatris has a valuation score of 71, which is 51 points higher than the pharmaceutical industry average of 20. It passed 5 out of 7 valuation due diligence checks.

Viatris's stock has dropped -16.77% in the past year. It has underperformed other stocks in the pharmaceutical industry by -1 percentage points.

2. Eagle Pharmaceuticals (NASDAQ:EGRX)


Eagle Pharmaceuticals (NASDAQ:EGRX) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Eagle Pharmaceuticals has a valuation score of 71, which is 51 points higher than the pharmaceutical industry average of 20. It passed 5 out of 7 valuation due diligence checks.

Eagle Pharmaceuticals's stock has dropped -83.89% in the past year. It has underperformed other stocks in the pharmaceutical industry by -68 percentage points.

3. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Collegium Pharmaceutical has a valuation score of 57, which is 37 points higher than the pharmaceutical industry average of 20. It passed 4 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has gained 17.19% in the past year. It has overperformed other stocks in the pharmaceutical industry by 33 percentage points.

Are pharmaceutical stocks a good buy now?

57.14% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 52.25% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 15.99x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.